Literature DB >> 21556407

Novel protection-deprotection strategies in diazeniumdiolate chemistry: synthesis of V-IPA/NO.

Rahul S Nandurdikar1, Larry K Keefer, Joseph E Saavedra.   

Abstract

Synthesis of previously inaccessible, potentially liver selective HNO donor V-IPA/NO ([iPrHN(3)-N(1)(O(1))=N(2)-O(2)-R], where R = vinyl) is reported here. A novel fluoride-labile TOM group at O-2 in conjunction with MOM protection at N-3 in IPA/NO is employed. The strategy developed is also extended to synthesis of other NO-releasing prodrugs and has applications in diversity-oriented synthesis of HNO- and NO-prodrugs. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556407      PMCID: PMC6959522          DOI: 10.1039/c1cc12130h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  18 in total

1.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

Review 2.  Small interfering RNAs and their chemical synthesis.

Authors:  Ronald Micura
Journal:  Angew Chem Int Ed Engl       Date:  2002-07-02       Impact factor: 15.336

3.  Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver.

Authors:  J E Saavedra; T R Billiar; D L Williams; Y M Kim; S C Watkins; L K Keefer
Journal:  J Med Chem       Date:  1997-06-20       Impact factor: 7.446

4.  The secondary amine/nitric oxide complex ion R(2)N[N(O)NO](-) as nucleophile and leaving group in S9N)Ar reactions.

Authors:  J E Saavedra; A Srinivasan; C L Bonifant; J Chu; A P Shanklin; J L Flippen-Anderson; W G Rice; J A Turpin; K M Davies; L K Keefer
Journal:  J Org Chem       Date:  2001-05-04       Impact factor: 4.354

Review 5.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

6.  Chemistry of the diazeniumdiolates: Z right harpoon over left harpoon E isomerism.

Authors:  Yan-Ni Wang; D Scott Bohle; Challice L Bonifant; Gwendolyn N Chmurny; Jack R Collins; Keith M Davies; Jeffrey Deschamps; Judith L Flippen-Anderson; Larry K Keefer; John R Klose; Joseph E Saavedra; David J Waterhouse; Joseph Ivanic
Journal:  J Am Chem Soc       Date:  2005-04-20       Impact factor: 15.419

7.  The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level.

Authors:  Wei Qu; Jie Liu; Richard Fuquay; Ryuya Shimoda; Teruaki Sakurai; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Nitric Oxide       Date:  2005-03       Impact factor: 4.427

8.  Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450.

Authors:  Keiko Inami; Raymond W Nims; Aloka Srinivasan; Michael L Citro; Joseph E Saavedra; Arthur I Cederbaum; Larry K Keefer
Journal:  Nitric Oxide       Date:  2006-03-20       Impact factor: 4.427

9.  Synthesis and pairing properties of oligoribonucleotide analogues containing a metal-binding site attached to beta-D-allofuranosyl cytosine.

Authors:  X Wu; S Pitsch
Journal:  Nucleic Acids Res       Date:  1998-10-01       Impact factor: 16.971

10.  Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-a-vis vascular smooth muscle relaxants.

Authors:  H T Nagasawa; S P Kawle; J A Elberling; E G DeMaster; J M Fukuto
Journal:  J Med Chem       Date:  1995-05-26       Impact factor: 7.446

View more
  2 in total

1.  Diazeniumdiolated carbamates: a novel class of nitric oxide donors.

Authors:  Rahul S Nandurdikar; Anna E Maciag; Zhao Cao; Larry K Keefer; Joseph E Saavedra
Journal:  Bioorg Med Chem       Date:  2012-02-04       Impact factor: 3.641

Review 2.  Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances.

Authors:  Larry K Keefer
Journal:  ACS Chem Biol       Date:  2011-09-30       Impact factor: 5.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.